These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 21173382)

  • 1. A novel epigenetic phenotype associated with the most aggressive pathway of bladder tumor progression.
    Vallot C; Stransky N; Bernard-Pierrot I; Hérault A; Zucman-Rossi J; Chapeaublanc E; Vordos D; Laplanche A; Benhamou S; Lebret T; Southgate J; Allory Y; Radvanyi F
    J Natl Cancer Inst; 2011 Jan; 103(1):47-60. PubMed ID: 21173382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Update on FGFR3 mutation and multiple regional epigenetic silencing (MRES) phenotype in urothelial carcinogenesis].
    Masson-Lecomte A; Vordos D; de la Taille A; Neuzillet Y; Radvanyi F; Allory Y
    Prog Urol; 2013 Feb; 23(2):96-8. PubMed ID: 23352301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic inactivation of ST6GAL1 in human bladder cancer.
    Antony P; Rose M; Heidenreich A; Knüchel R; Gaisa NT; Dahl E
    BMC Cancer; 2014 Dec; 14():901. PubMed ID: 25465919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OASIS/CREB3L1 is epigenetically silenced in human bladder cancer facilitating tumor cell spreading and migration in vitro.
    Rose M; Schubert C; Dierichs L; Gaisa NT; Heer M; Heidenreich A; Knüchel R; Dahl E
    Epigenetics; 2014 Dec; 9(12):1626-40. PubMed ID: 25625847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells.
    Zhang C; Li H; Zhou G; Zhang Q; Zhang T; Li J; Zhang J; Hou J; Liew CT; Yin D
    J Pathol; 2007 Jun; 212(2):134-42. PubMed ID: 17471463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter- and cell-specific epigenetic regulation of CD44, Cyclin D2, GLIPR1 and PTEN by methyl-CpG binding proteins and histone modifications.
    Müller I; Wischnewski F; Pantel K; Schwarzenbach H
    BMC Cancer; 2010 Jun; 10():297. PubMed ID: 20565761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tumorigenesis from a pathological perspective : Tumor spread and epigenetically regulated genes in bladder cancer].
    Gaisa NT
    Pathologe; 2016 Nov; 37(Suppl 2):196-203. PubMed ID: 27613302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of epigenetic regulation of the tumor suppressor gene cluster flanking RASSF1 in breast cancer cell lines.
    da Costa Prando E; Cavalli LR; Rainho CA
    Epigenetics; 2011 Dec; 6(12):1413-24. PubMed ID: 22139571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-expression of methylation-induced tumor suppressor gene silencing is associated with the state of histone modification in gastric cancer cell lines.
    Meng CF; Zhu XJ; Peng G; Dai DQ
    World J Gastroenterol; 2007 Dec; 13(46):6166-71. PubMed ID: 18069755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of activating fibroblast growth factor receptor 3 mutations in the development of bladder tumors.
    Zieger K; Dyrskjøt L; Wiuf C; Jensen JL; Andersen CL; Jensen KM; Ørntoft TF
    Clin Cancer Res; 2005 Nov; 11(21):7709-19. PubMed ID: 16278391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromatin composition alterations and the critical role of MeCP2 for epigenetic silencing of progesterone receptor-B gene in endometrial cancers.
    Chu Y; Wang Y; Zhang G; Chen H; Dowdy SC; Xiong Y; Liu F; Zhang R; Li J; Jiang SW
    Cell Mol Life Sci; 2014 Sep; 71(17):3393-408. PubMed ID: 24531693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
    Mossman D; Kim KT; Scott RJ
    BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRC2-independent chromatin compaction and transcriptional repression in cancer.
    Vallot C; Hérault A; Boyle S; Bickmore WA; Radvanyi F
    Oncogene; 2015 Feb; 34(6):741-51. PubMed ID: 24469045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long term transcriptional reactivation of epigenetically silenced genes in colorectal cancer cells requires DNA hypomethylation and histone acetylation.
    Mossman D; Scott RJ
    PLoS One; 2011; 6(8):e23127. PubMed ID: 21829702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma.
    Lee MG; Kim HY; Byun DS; Lee SJ; Lee CH; Kim JI; Chang SG; Chi SG
    Cancer Res; 2001 Sep; 61(18):6688-92. PubMed ID: 11559536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium-sensing receptor silencing in colorectal cancer is associated with promoter hypermethylation and loss of acetylation on histone 3.
    Fetahu IS; Höbaus J; Aggarwal A; Hummel DM; Tennakoon S; Mesteri I; Baumgartner-Parzer S; Kállay E
    Int J Cancer; 2014 Nov; 135(9):2014-23. PubMed ID: 24691920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic regulation of O6-methylguanine-DNA methyltransferase gene expression by histone acetylation and methyl-CpG binding proteins.
    Danam RP; Howell SR; Brent TP; Harris LC
    Mol Cancer Ther; 2005 Jan; 4(1):61-9. PubMed ID: 15657354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer.
    Taniguchi H; Yamamoto H; Akutsu N; Nosho K; Adachi Y; Imai K; Shinomura Y
    J Pathol; 2007 Oct; 213(2):131-9. PubMed ID: 17724792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression.
    Babbio F; Pistore C; Curti L; Castiglioni I; Kunderfranco P; Brino L; Oudet P; Seiler R; Thalman GN; Roggero E; Sarti M; Pinton S; Mello-Grand M; Chiorino G; Catapano CV; Carbone GM; Bonapace IM
    Oncogene; 2012 Nov; 31(46):4878-87. PubMed ID: 22330138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consistent genomic alterations in carcinoma in situ of the urinary bladder confirm the presence of two major pathways in bladder cancer development.
    Zieger K; Marcussen N; Borre M; Ørntoft TF; Dyrskjøt L
    Int J Cancer; 2009 Nov; 125(9):2095-103. PubMed ID: 19637316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.